Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Medtech

+ Watchlist
BFLHBCH:LX
217.85
CHF
0.76
0.35%
As of 08:16:00 ET on 08/03/2015.
Fund Type
SICAV
52Wk Range
177.12 - 218.61
1 Yr Return
20.31%
YTD Return
5.96%
Previous Close
218.61
52Wk Range
177.12 - 218.61
1 Yr Return
20.31%
YTD Return
5.96%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 08/03/2015)
217.85
Total Assets (m EUR) (on 08/03/2015)
144.946
Inception Date
01/31/2011
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
STEFAN BLUM / MARCEL FRITSCH
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.60%
Expense Ratio
2.37%
Top Fund Holdings
Name Position Value % of Fund
Abbott Laboratories 300.00 k 13.21 m 10.13
Medtronic PLC 150.00 k 9.98 m 7.65
Stryker Corp 105.70 k 9.07 m 6.95
St Jude Medical Inc 110.00 k 7.21 m 5.53
Zimmer Biomet Holdings Inc 70.50 k 6.91 m 5.30
Becton Dickinson and Co 50.00 k 6.36 m 4.87
Boston Scientific Corp 400.00 k 6.35 m 4.87
Essilor International SA 46.50 k 4.98 m 3.82
Intuitive Surgical Inc 9.55 k 4.15 m 3.18
Smith & Nephew PLC 262.84 k 3.98 m 3.06
Profile
Bellevue Funds (Lux) - BB Adamant Medtech is an open-end fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the medtech sector. The focus is on companies engaged in research, development, manufacturing, supply or sale of medical equipment.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00